<DOC>
	<DOC>NCT00440622</DOC>
	<brief_summary>The optimal treatment for pretreated patients with metastatic breast cancer has not been established. Gemcitabine and capecitabine are two active agents in this setting. For women with Her-2 positive breast cancer, combinations of either gemcitabine or capecitabine (Xeloda) plus Herceptin has been proved active and well tolerated.</brief_summary>
	<brief_title>Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients</brief_title>
	<detailed_description>This trial compares the efficacy of the combinations gemcitabine plus Herceptin versus capecitabine (Xeloda) plus Herceptin in pretreated patients with metastatic HER-2 positive breast cancer.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Informed consent Histologically confirmed metastatic breast adenocarcinoma (stage IV) without any prior chemotherapy received HER2 overexpression 2+ or 3+ using IHC or FISH + Measurable disease At least one prior chemotherapy regimen Not in a prior irradiation field No patients with brain metastatic disease who has not been irradiated or uncontrolled brain metastatic disease after irradiation No more than 25% of myeloproductive bone marrow irradiated. More than 4 weeks since prior radiotherapy and recovered Age 18 75 year old Performance status (WHO) 02 Life expectancy more than 12 weeks Absolute neutrophil count &gt; 1500/mm^3, platelet count &gt; 100000/mm^3, hemoglobin &gt; 9 gr/mm^3) Adequate liver (bilirubin &lt; 2 mg/dL, SGOT/SGPT &lt; 2 times upper limit of normal, ALP &lt; 3 times upper limit of normal, creatinine &lt; 1.5 upper limit of normal Adequate cardiac function (LVEF &gt; 50%) Pregnant or nursing Positive pregnancy test Concurrent agents ketoconazole, macrolide antibiotics, zidovudine which may induce P450 cytochrome Motor or sensory neuropathy &gt; grade 1 according to NCIC toxicity criteria History of allergic reaction attributed to docetaxel Psychiatric illness or social situation that would preclude study compliance Other concurrent uncontrolled illness Other invasive malignancy within the past 5 years except cured basal cell skin carcinoma and cervical carcinoma in situ</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Metastatic Breast cancer</keyword>
	<keyword>Her-2 expression</keyword>
	<keyword>Gemcitabine</keyword>
	<keyword>Capecitabine</keyword>
	<keyword>Herceptin</keyword>
</DOC>